NeuroVigil, Inc. is a leading neurotechnology company focused on the analysis of brain signal or EEG data, which currently is used in numerous medical applications but is not automated.

NeuroVigil has three products developed to help pharmaceutical companies conduct outpatient clinical trials, ALS sufferers communicate and NASA track astronauts on the International Space Station. The company is headquartered in La Jolla and has a satellite operation at NASA Ames Research Park in Silicon Valley. The company is headed by neurotechnology pioneer and entrepreneur, Dr. Philip Low, an MIT TR-35 recipient and Jacobs-Rady Pioneer for Global Innovation and Entrepreneurship, and backed by Elon Musk and Irwin Jacobs. The company's clients include Roche and Novartis as clients and its advisors include Stephen Hawking, Stephen Wolfram and Nobel laureates Roger Guillemin and Sydney Brenner.

NeuroVigil won the DFJ and UCSD challenges and was singled out by Fast Company and The Washington Post as one of the Top 10 Most Innovative Companies in Health Care. The Company's iBrain, the world's first mobile brain monitor, won the CONNECT Most Innovative New Product in Health Care and was identified by the New York Times, as one of the "Innovations That Will Change Your Tomorrow". On May 1st 2011, NeuroVigil closed the highest valuation first round investment of any startup in history, over twice Google's and Facebook's first round valuations combined.